0001179110-20-000001.txt : 20200102
0001179110-20-000001.hdr.sgml : 20200102
20200102092719
ACCESSION NUMBER: 0001179110-20-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191231
FILED AS OF DATE: 20200102
DATE AS OF CHANGE: 20200102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MITCHELL DEAN J
CENTRAL INDEX KEY: 0001199297
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17999
FILM NUMBER: 20500326
MAIL ADDRESS:
STREET 1: C/O BRISTOL MYERS SQUIBB CO
STREET 2: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10164
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ImmunoGen, Inc.
CENTRAL INDEX KEY: 0000855654
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042726691
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781)895-0600
MAIL ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOGEN INC
DATE OF NAME CHANGE: 19920703
4
1
edgar.xml
FORM 4 -
X0306
4
2019-12-31
0
0000855654
ImmunoGen, Inc.
IMGN
0001199297
MITCHELL DEAN J
45 HODGE ROAD
PRINCETON
NJ
08540
1
0
0
0
Deferred Share Unit
0
2019-12-31
4
A
0
2641
0
A
2019-12-31
Common Stock
2641
62373
D
The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis.
The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors.
The deferred share units vest upon issuance.
/s/ Craig Barrows, attorney in fact
2020-01-02